PURR:NASDAQ, Hyperliquid Strategies Inc

Why PURR stock fell on November 20

Hyperliquid Strategies Inc fell 11.0% on Friday, November 20, 2026, on 19,337,717 shares. No headline about PURR came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.

PURR stock overview

Hyperliquid Strategies Inc (PURR:NASDAQ) closed at $7.48 on November 20, 2026, down 10.95% on the day. The stock trades 49.3% below its 52-week high of $14.76 and 148.5% above its 52-week low of $3.01. Over the past year, it gained 91.8%. Hyperliquid Strategies Inc is part of the Health Care sector.

Key figures

Price
$7.48
Day change
-10.95%
Volume
19,337,717
Average volume
20,054,181
Market cap
2B+
52-week range
$3.01 – $14.76
50-day average
$10.63
200-day average
$7.98

Price action over the past year

In 243 trading sessions since December 4, 2025, PURR closed higher on 115 days (47%). Its best day was August 19, 2026 (+30.42%) and its worst was February 23, 2026 (-11.89%). The stock moved 10% or more in a single session 25 times. It opened at least 5% above the previous day's high 9 times.

Recent signals

PURR news

About Hyperliquid Strategies Inc

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

Similar stocks

Find more stocks like PURR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.